RAND's divisions conduct research on a uniquely broad front for clients around the globe.
Most relevant regions
Expert Insights
Mar 11, 2015
This paper offers a research-grounded perspective on innovative financing mechanisms to facilitate access to expensive yet highly effective breakthrough medical treatments.
Press
In an era of $1,000-a-pill medications, a new approach may be needed to finance an emerging breed of highly expensive pharmaceuticals and vaccines. Health care could learn from other industries, where it is common for suppliers to encourage investment through approaches such as equipment leases or supplier-financed credit.
Research
Jan 11, 2013
Work presented in this report sought to assess the healthcare and economic burden of the hepatitis C virus (HCV) infection in the United Kingdom using a cohort simulation model.
Aug 1, 2012
This study of condom use among homeless youth in Los Angeles County found that a broad range of individual, relationship, and contextual factors play a role in condom use.
Oct 1, 2011
African American men view sexual relationships with non-main partners as riskier; concurrent relationships are acceptable and often expected.
Sep 1, 2011
A patient's decision to start or defer hepatitis C treatment is influenced by the stage of their disease and by their providers' confidence about the efficacy of hepatitis C treatment.
Jan 1, 2011
Good mental health may be an indicator of readiness to adhere to treatment for Hepatitis C among individuals who also have HIV.
Jan 1, 2010
California pharmacies are more likely to participate in a voluntary program allowing limited sale of syringes to adults without a prescription if they think syringe access is important for preventing HIV among drug users.
Many California local health jurisdictions with significant numbers of HIV cases have approved disease prevention demonstration projects, which permit limited sale of syringes to adults without a prescription
Jan 1, 2009
Liver disease is a leading cause of death among patients with HIV coinfected with hepatitis C (HCV); yet, studies show that less than 10% receive HCV treatment, in part because of limited treatment response, high treatment toxicity, and psychosocial barri
Jan 1, 2007
Study results suggest that integrating HIV and HCV C&T can increase disease screening rates among IDUs.
Efforts to increase the availability of HIV and HCV testing services at syringe exchange programs and the use of existing testing services are needed.
